Published in J Med Genet on December 01, 1966
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med (2016) 3.68
Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest (1973) 2.65
Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet (2004) 2.36
Molecular genetics of coronary artery disease. Curr Opin Cardiol (2005) 1.58
Reliability of reported family history of myocardial infarction. BMJ (1993) 1.52
ABO blood groups and ischaemic heart disease in men. Br Heart J (1968) 1.47
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet (2006) 1.29
Coronary artery disease and its risk factors in families of young men with angina pectoris and in controls. Br Heart J (1977) 1.28
Aggregation of coronary risk factors in families of men with fatal and non-fatal coronary heart disease. Br Heart J (1979) 1.26
Some difficulties in the investigation of genetic factors in coronary artery disease. Can Med Assoc J (1967) 1.19
Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study. Circulation (2012) 1.18
Familial aggregation of coronary heart disease in a high incidence area (North Karelia, Finland). Br Heart J (1979) 1.12
Family history of myocardial infarction as an independent risk factor for coronary heart disease. Br Heart J (1985) 1.09
Genome-wide association study in a Lebanese cohort confirms PHACTR1 as a major determinant of coronary artery stenosis. PLoS One (2012) 1.03
Genome-wide association studies of coronary artery disease and heart failure: where are we going? Pharmacogenomics (2009) 1.00
Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study. Am J Epidemiol (2009) 1.00
Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis. J Med Genet (1968) 0.97
Relation of familial patterns of coronary heart disease, stroke, and diabetes to subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Genet Med (2008) 0.96
Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study. BMC Med (2008) 0.95
Identifying genes for coronary artery disease: An idea whose time has come. Can J Cardiol (2007) 0.90
Familial hyperlipidaemias. Proc R Soc Med (1967) 0.89
Family history in "low risk" men with coronary heart disease. J Epidemiol Community Health (1983) 0.85
Non-modifiable Factors of Coronary Artery Stenosis in Late Onset Patients with Coronary Artery Disease in Southern Iranian Population. J Cardiovasc Thorac Res (2014) 0.84
Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry. Korean J Intern Med (2013) 0.84
Risk factors for coronary heart disease in Hawaiian and Japanese males in Hawaii. J Med Genet (1969) 0.81
Hypertension in general practice. J R Soc Med (1978) 0.81
ABO blood groups and gastrointestinal function. Gut (1970) 0.80
Genetic vulnerability and phenotypic expression of depression and risk for ischemic heart disease in the Vietnam era twin study of aging. Psychosom Med (2010) 0.79
Genes and the development of vascular disease. Postgrad Med J (1997) 0.78
Complex trait genetics the role of mechanistic "intermediate phenotypes" and candidate genetic loci. J Am Coll Cardiol (2008) 0.77
Vascular mortality in patients with gout and in their families. Ann Rheum Dis (1983) 0.76
Cardiovascular risk factors among children of men with premature myocardial infarction. Public Health Rep (1981) 0.75
Vascular disease of the central nervous system in Wales. J Med Genet (1967) 0.75
Management of myocardial infarction in young women. Br Med J (1977) 0.75
Genetics of coronary artery disease and myocardial infarction. World J Cardiol (2016) 0.75
Strong family history and cigarette smoking as risk factors of coronary artery disease in young adults. Br Heart J (1982) 0.75
Familial incidence of cerebrovascular disease. J Med Genet (1971) 0.75
Coronary disease and risk factors in close relatives of Utah women with early coronary death. West J Med (1986) 0.75
Coronary artery disease in Wales. J Med Genet (1967) 0.75
Why does coronary heart disease run in families? Br Med J (1977) 0.75
Associations of Apolipoprotein A, High-Sensitivity C-Reactive Protein and Fasting Plasma Insulin in Obese Children With and Without Family History of Cardiovascular Disease. J Clin Med Res (2016) 0.75
Thrombosis in coronary heart disease. Br Heart J (1968) 0.75
The familial occurrence of hypertension and coronary artery disease, with observations concerning obesity and diabetes. Ann Intern Med (1955) 3.95
FAMILIAL PATTERNS IN ISCHAEMIC HEART DISEASE. Br J Prev Soc Med (1964) 3.51
Genetic clinic. A follow-up. Lancet (1971) 6.06
Presenting a routine screening test in antenatal care: practice observed. Public Health (1992) 5.34
Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet (1969) 5.13
Inheritance of congenital pyloric stenosis. J Med Genet (1969) 5.05
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med (1980) 3.13
An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentration. Soc Sci Med (1987) 2.69
Spinal dysraphism: genetic relation to neural tube malformations. J Med Genet (1976) 2.41
Identification of the cystic fibrosis gene. BMJ (1990) 2.34
Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ (1990) 2.17
Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology (1991) 1.97
Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet (1972) 1.95
Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc Natl Acad Sci U S A (1989) 1.90
Genetic epidemiology of breast cancer in Britain. Ann Hum Genet (1991) 1.89
Coning and lumbar puncture. Lancet (1980) 1.78
Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J (1977) 1.71
Inherited disorders associated with colorectal cancer. Cancer Surv (1989) 1.70
Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet (1977) 1.67
Deaths from meningococcal infection in England and Wales in 1978. J R Coll Physicians Lond (1982) 1.65
Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res (1988) 1.60
Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis. J Med Genet (1968) 1.59
Risk estimates for screening adenomatous polyposis coli. Lancet (1990) 1.58
Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med (1979) 1.54
The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn (1992) 1.53
Effect of supplemental oxygen on cardiopulmonary changes during gastrointestinal endoscopy. Gastrointest Endosc (1995) 1.48
Screening for Down's syndrome. BMJ (1988) 1.48
Influence of heredity and environment in determination of skinfold thickness in children. Br Med J (1975) 1.41
Lack of knowledge in health professionals: a barrier to providing information to patients? Qual Health Care (1994) 1.35
Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J Exp Med (1980) 1.34
Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro. J Immunol (1990) 1.33
Dominant genes for colorectal cancer are not rare. Ann Hum Genet (1992) 1.30
Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med (1994) 1.30
B cell subsets and differential responses to mitogens. Immunol Rev (1982) 1.26
Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA. J Biol Chem (1990) 1.26
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma. Leukemia (2008) 1.24
Factors influencing the uptake of screening for open neural-tube defects and amniocentesis to test for Down's syndrome. Br J Obstet Gynaecol (1989) 1.19
Family history and risk of breast cancer. J Med Genet (1992) 1.18
Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London. Br Med J (1977) 1.18
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
Severity of disease induced by a pancreatropic Coxsackie B4 virus correlates with the H-2Kq locus of the major histocompatibility complex. Virus Res (1989) 1.13
Family similarities in the age at coronary death in familial hypercholesterolaemia. Br Med J (1977) 1.12
Altered free radical metabolism in acute mountain sickness: implications for dynamic cerebral autoregulation and blood-brain barrier function. J Physiol (2008) 1.11
Genetic epidemiology of ovarian cancer: segregation analysis. Ann Hum Genet (1991) 1.10
Screening for Down's syndrome in the North East Thames region. Br Med J (Clin Res Ed) (1985) 1.10
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol (1994) 1.10
The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab (1995) 1.10
Inheritance and bleeding in factor XI deficiency. Br J Haematol (1988) 1.02
Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom. Br J Surg (1990) 1.00
Psychological effects of having amniocentesis: are these due to the procedure, the risk or the behaviour? J Psychosom Res (1992) 0.99
Genetic differences in liability to atherosclerotic heart disease. J R Coll Physicians Lond (1974) 0.98
Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis. J Med Genet (1968) 0.97
IL-1 induces rapid phosphorylation of the IL-1 receptor. J Immunol (1989) 0.93
Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes. Leukemia (2003) 0.93
Family study of lipid and purine levels in gout patients. Ann Rheum Dis (1982) 0.93
Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome. J Virol (1990) 0.92
A family study of the late infantile and juvenile forms of metachromatic leucodystrophy. J Med Genet (1966) 0.92
Role of CO2 in the formation of gold deposits. Nature (2004) 0.92
Genetics of hyperlipoproteinaemias. Lancet (1971) 0.91
Restriction in the immune response to flagellar proteins in inbred mice. Eur J Immunol (1977) 0.91
Congenital hypertrophy of retinal pigment epithelium in patients with colonic polyps associated with cancer family syndrome. Clin Genet (1992) 0.90
Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic. J Med Genet (1992) 0.90
Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity. J Immunol (1993) 0.90
Perceived risk not actual risk predicts uptake of amniocentesis. Br J Obstet Gynaecol (1991) 0.87
Diagnosing familial hypercholesterolaemia in childhood. Br Med J (1977) 0.87
Anomalous low density lipoproteins in familial hyperbetalipoproteinaemia. Clin Chim Acta (1970) 0.87
Effect of genetic counselling on the prevalence of Huntington's chorea. Br Med J (Clin Res Ed) (1983) 0.86
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant (2003) 0.84
Use of family history in a screening clinic for familial ovarian cancer. Gynecol Oncol (1992) 0.83
Training obstetricians and midwives to present screening tests: evaluation of two brief interventions. Prenat Diagn (1995) 0.83
Dielectric properties of normal and abnormal lipoproteins in aqueous solution. Ann N Y Acad Sci (1977) 0.83
Behavioural response of wheat bulb fly (Delia coarctata, Diptera: Anthomyiidae) larvae to the primary plant metabolite carbon dioxide. Bull Entomol Res (2013) 0.82
Urinary polyamine excretion patterns in patients with epithelial ovarian cancer. Gynecol Obstet Invest (1989) 0.81
Risk of ovarian cancer and genetic relationship to other cancers in families. Hum Hered (1993) 0.81
Type II hyperlipoproteinaemia. Clin Endocrinol Metab (1973) 0.81
Risk factors in coronary heart-disease. Lancet (1977) 0.81
Turnover of cholesteryl esters in plasma low-density and high-density lipoproteins in familial hyperbetalipoproteinaemia. Clin Sci Mol Med (1973) 0.80
Wheat bulb fly (Delia coarctata, Fallén, Diptera: Anthomyiidae) larval response to hydroxamic acid constituents of host-plant root exudates. Bull Entomol Res (2013) 0.80
Effects of intraocular irrigants on the preserved human corneal endothelium. Cornea (1991) 0.80
Progression of atheroma in homozygous familial hypercholesterolaemia during regular plasma exchange. Lancet (1981) 0.80
A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor. Cancer Chemother Pharmacol (1989) 0.79
The genetic contribution to coronary heart disease through lipoprotein concentrations. Postgrad Med J (1975) 0.79
Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation. Neurodegener Dis (2011) 0.79
Characterization of several new MHC congenic strains. Immunogenetics (1991) 0.79
The effects of hypohydration on central venous pressure and splenic volume in adult horses. J Vet Intern Med (2010) 0.78
Derivatization LC/MS for the simultaneous determination of fatty alcohol and alcohol ethoxylate surfactants in water and wastewater samples. Environ Sci Technol (2001) 0.78
Echocardiographic changes in heart size in hypohydrated horses. J Vet Intern Med (2010) 0.78
A Rosetta stone for pattern formation in animals? Nature (1984) 0.77
Helper T cell-independent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirus. J Immunol (1994) 0.77
Microcephaly, focal segmental glomerulonephritis and marfanoid habitus in two sibs. Clin Dysmorphol (1992) 0.77
A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia. Br J Dermatol (1974) 0.76
Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation. Bone Marrow Transplant (1999) 0.76
Proceedings: The relation of antihypertensive treatment to plasma lipids and other vascular risk factors in hypertensives. Clin Sci Mol Med (1974) 0.76
Vascular mortality in patients with gout and in their families. Ann Rheum Dis (1983) 0.76
Embryology. Molecule of the moment. Nature (1991) 0.76
Headless tadpoles and an informed public. Nature (1997) 0.75
Prenatal diagnosis of Conradi's syndrome. Case report. Prenat Diagn (1990) 0.75
Lipid disorders and heart-disease. Lancet (1970) 0.75
Molecular heterogeneity of interleukin-1 receptors. Ann N Y Acad Sci (1990) 0.75
A dielectric investigation of the water of hydration of low-density lipoproteins in familial hyperbetalipoproteinaemia. Lancet (1972) 0.75
3D-printed poly(vinylidene fluoride)/carbon nanotube composites as a tunable, low-cost chemical vapour sensing platform. Nanoscale (2017) 0.75